Add Yahoo as a preferred source to see more of our stories on Google. This October 2024 image provided by Novartis shows GanLum, a new anti-malaria treatment, at a manufacturing facility in Slovenia. ...
Landmark findings from a major malaria clinical trial led by Menzies School of Health Research (Menzies) and international ...
For the first time in history, newborns and very young infants have access to a malaria treatment tailored to their unique needs. On July 8, Swissmedic – Switzerland’s regulatory agency – greenlit ...
The approval of the first malaria treatment for newborns and young infants could lead to imminent widespread use in Africa, drugmaker Novartis said Tuesday. The drug, known as Coartem Baby or Riamet ...
Clinical Trial in Africa Finds Single-Dose Malaria Treatment Combining Four Existing Drugs as Effective as More Onerous Multi-Day, Multi-Dose Regimen Research advance from Gabon presented at the ...
The anti-malarial drug Artemisinin is highly effective. It's critical for kids, who are especially vulnerable. A new study comes to an alarming... What's going on with the 'magic' drug for malaria?
This October 2024 image provided by Novartis shows GanLum, a new anti-malaria treatment, at a manufacturing facility in Slovenia. (Novartis via AP) NEW YORK (AP) — Researchers on Wednesday reported ...
NEW YORK — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs. Switzerland-based Novartis ...
NEW YORK (AP) — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs. Switzerland-based Novartis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results